Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(11%)
Results Posted
86%(6 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_3
5
56%
Ph phase_2
3
33%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
5(55.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (11.1%)
Phase 23 (33.3%)
Phase 35 (55.6%)

Trials by Status

completed778%
terminated111%
active_not_recruiting111%

Recent Activity

1 active trials
Showing 5 of 9
completedphase_2

Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis

NCT05152173
active_not_recruitingphase_3

Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)

NCT06151197
completedphase_3

Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis

NCT05254457
completedphase_2

Safety and Efficacy of EN3835 in Participants With Frozen Shoulder

NCT04496167
completedphase_3

Real World CCH Study in Adult Females With Cellulite

NCT04170296
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05152173Phase 2

Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis

Completed
NCT06151197Phase 3

Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)

Active Not Recruiting
NCT05254457Phase 3

Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis

Completed
NCT04496167Phase 2

Safety and Efficacy of EN3835 in Participants With Frozen Shoulder

Completed
NCT04170296Phase 3

Real World CCH Study in Adult Females With Cellulite

Completed
NCT04209530Phase 2

Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women

Terminated
NCT03446781Phase 3

Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women

Completed
NCT03428750Phase 3

Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Completed
NCT02889848Phase 1

Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)

Completed

All 9 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
9